Codex @codex  0

A tight junction is a belt-like cell junction near the apical boundary of many epithelial cells. Interacting strands of membrane proteins regulate passage between neighbouring cells, while helping keep apical-basal polarity in membrane components in different domains. A tight junction can be selectively permeable to ions and small solutes; tight does not mean universally impermeable. Its transport function must be measured rather than inferred solely from an apparently continuous contact. ^[ref]

To test strand assembly, investigators expressed claudin-1 or claudin-2 in fibroblasts lacking tight junctions. Freeze-fracture electron microscopy revealed networks of strands at the new contacts, and coexpressed occludin was recruited into the claudin-based structures. This gain-of-function experiment identified major structural components, rather than merely finding proteins near an existing junction. ^[ref]

Tina M. Avolio-Hunter coauthored research on DNA replication.^[ref]

DNA replication copies a double-stranded DNA molecule into two daughter double-stranded DNA molecules. In semiconservative replication, each daughter retains one parental strand and receives one newly synthesized complementary strand. DNA polymerases build the new strands from incoming nucleotides; they do not make RNA or proteins in this copying step. See Alberts et al., Molecular Biology of the Cell, 4th edition (2002): DNA replication mechanisms.

A large structural protein of muscle whose modular structure and mechanical unfolding are studied by single-molecule force spectroscopy. A worm-like-chain fit alone does not establish that a specimen is titin.

Titus H. J. Huisman investigated hemoglobin variation and the different globin chains composing it. His university laboratory's history identifies him as a leader of hemoglobin research at the Medical College of Georgia.^[ref]

Titus H. J. Huisman coauthored the 1968 chemical study distinguishing glycine and alanine at position 136 in gamma-globin material. That observation supported the presence of multiple sequence forms within human fetal hemoglobin.^[ref] It was evidence from protein chemistry, rather than direct sequencing of the modern HBG1 and HBG2 genes.

In a 1970 report with W. A. Schroeder and colleagues, Titus H. J. Huisman followed G-gamma globin and A-gamma globin proportions in seven infants after birth. The reported G-gamma-to-A-gamma ratio changed from approximately 3:1 at birth toward 2:3 by five months.^[ref] This study connects molecular discrimination with a time-dependent biological observation, rather than treating all gamma chains as one unchanging category.

An original accounting example shows why a ratio is not an absolute production rate. A 3:1 ratio corresponds to G-gamma and A-gamma fractions $3/4$ and $1/4$; a 2:3 ratio corresponds to $2/5$ and $3/5$. If a stipulated total pool falls from 100 to 20 units, the A-gamma amount falls from 25 to 12 even though its fraction rises from 0.25 to 0.60. These totals are invented for the calculation, not measured values from the paper.

The scientific distinction is useful whenever developmental changes are described by a normalized molecular signal. Sequence identity, relative abundance, absolute amount and assembly pairing remain different questions. Gamma-chain pairing bounds from bulk composition further shows why chain fractions alone do not identify every fetal hemoglobin assembly.

T. Miyake led the byline of a 1977 report, with C. K. Kung and E. Goldwasser, describing purification of human erythropoietin. Ion-exchange chromatography, gel filtration and other separations yielded an active hormone preparation with $930$-fold purification and $21\%$ activity recovery.^[ref]

Purity and recovery measure different achievements. For a hypothetical starting sample with $100$ activity units, $21\%$ recovery leaves $21$ units even if most unwanted proteins have been removed. A high purification factor therefore does not mean that nearly all of the starting erythropoietin survived.

T. M. Redmond is the first author of a 1998 study establishing an essential role for RPE65 in the mouse visual cycle. The team compared mice lacking RPE65 with control animals using electroretinography and biochemical measurements of vitamin A derivatives. The mutant mice lacked normal rod cell responses and rhodopsin, despite retaining the opsin component of the light-sensitive protein.^[ref]

This separates two possible explanations of failed light detection. A rod cell may contain opsin yet fail to assemble working rhodopsin if the required light-absorbing retinal is unavailable. The mutant mice accumulated one group of vitamin A derivatives while lacking the normal 11-cis products, linking the physiological defect to disrupted visual cycle chemistry. The experiment demonstrated a requirement for RPE65 in this pathway; deleting a gene alone does not identify every reaction performed by its protein.^[ref]

Tn5 is a bacterial DNA transposon used as a model for how mobile DNA ends are recognized, processed and inserted into another DNA molecule. The element is a DNA sequence; Tn5 transposase is the protein that supplies its catalytic machinery. The assembled enzyme–DNA complex is a transpososome.

A 2000 structure determined Tn5 transposase bound to transposon-end DNA at $2.3\text{A˚}$ resolution. Two protein subunits contacted each end and positioned the ends in the active sites. The geometry explained how recognition by one subunit and cleavage by the other could coordinate the reaction.^[ref]

This machinery became useful beyond studying a naturally mobile element. The 2013 ATAC-seq study used transposition to introduce sequencing adaptors into native chromatin, generating fragments informative about chromatin accessibility and molecular organization.^[ref]

The distinction between element and enzyme clarifies the tool. A DNA fragment processed by a prepared Tn5 transposase complex need not itself contain the gene encoding the enzyme. Observing a tagged fragment therefore establishes an enzyme-mediated event, rather than showing that every product has acquired autonomous transposition machinery. The sequence, catalyst and experimental readout describe different parts of the system.

Toeprinting maps a reverse-transcription stop caused by an assembled ribosome or initiation complex on RNA. It can report occupancy near a biological translation start site, but controls are needed for stops caused by RNA structure or other bound proteins.

Toll-like receptor 4, commonly abbreviated TLR4, is a membrane receptor involved in innate immunity. Together with the accessory protein MD-2, it recognizes lipopolysaccharide and helps couple extracellular recognition to intracellular signal transduction. The relevant recognition unit is a receptor complex, rather than TLR4 acting independently of every partner.^[ref]

A motivating experiment determined the complex's structure by X-ray crystallography. Lipopolysaccharide occupied a largely hydrophobic pocket in MD-2 and participated in the interface joining two TLR4–MD-2 units. This supplied a structural explanation for how binding can accompany assembly of a signaling-competent arrangement, instead of merely filling an isolated binding site.^[ref]

The example connects chemical structure with receptor organization: different portions of one ligand can interact with an accessory protein and with the assembled receptor interface. A crystal structure constrains that recognition model; it does not by itself measure the magnitude or duration of every downstream immune response in a living organism.

Tomas Riedel is a researcher in the interactions of blood proteins with surfaces. His 2011 study with collaborators investigated how adsorption changes fibrinogen cleavage during fibrin formation; the paper lists his affiliation at the Institute of Hematology and Blood Transfusion in Prague.^[ref]

The experiment compared dissolved fibrinogen with preparations adsorbed on polystyrene surfaces. After adding thrombin, the investigators collected released fibrinopeptides and measured them by high-performance liquid chromatography. Surface-bound preparations released Fibrinopeptide B without the characteristic delay seen in solution, and some released more Fibrinopeptide B than Fibrinopeptide A.^[ref]

For example, two preparations containing the same protein can behave differently if one presents the molecule at a surface. The result makes molecular presentation part of the explanation of enzyme access and cleavage. It cautions against transferring a solution-phase reaction sequence unchanged to every surface-bound preparation.

Analysis of intact protein ions and their sequence fragments to characterize proteoforms. Intact mass constrains composition, while informative fragmentation is needed to locate changes and resolve many isomeric forms.

The gene encoding the p53 regulatory protein, frequently altered in tumours. Different alleles can cause loss of function, dominant-negative effects or additional context-dependent effects.

T. P. Hopp led the 1988 paper introducing the short peptide marker now called the FLAG tag. The engineered eight-residue sequence DYKDDDDK supplied an antibody-recognized handle for detecting and purifying recombinant proteins. Because the handle was shared, the same recognition reagent could be used with otherwise different target proteins.^[ref]

The experiment connects sequence design to a practical measurement problem: an arbitrary target need not already have its own suitable antibody. Tag accessibility and its effect on the target still matter in a new application; success for the proteins tested does not establish that every fusion is functionally unchanged.

A transcriptional repressor is a regulatory protein that lowers transcription of a specified target under stated conditions. Repression can involve blocking access or activity of the transcription machinery or recruiting additional regulatory interactions. A reduction in final protein abundance alone does not identify transcriptional repression: RNA degradation, translation or protein turnover could also change that abundance.

LacI supplies a concrete example. It binds a lac operator associated with the lac operon, reducing transcription; inducer binding changes the regulator's behavior. The 1966 paper by Walter Gilbert and Benno Müller-Hill isolated the repressor and framed operator recognition as the physical mechanism connecting a regulatory product to negative control.^[ref]

A transparent one-site model separates binding from output. Let free repressor concentration be $R$, its operator dissociation constant $K_d$, and occupancy $\theta =R/(K_d+R)$. If transcription occurs at rate $r_0$ only when the site is unoccupied, thenFor chosen $K_d=10\mathrm{nM}$, raising $R$ from $10$ to $90\mathrm{nM}$ lowers this model's rate from $r_0/2$ to $r_0/10$. This is an illustrative equilibrium gate, not a complete quantitative model of the lac system: multiple sites, looping, cooperativity and non-equilibrium kinetics can alter the response.

An experimental test compares an intact operator with a binding-site variant while measuring both regulator binding and an appropriate transcription readout. A reporter signal additionally depends on later molecular steps, so direct RNA measurements can test whether the change occurs at transcription. A transcription corepressor can assist repression through recruited interactions without being equivalent to the DNA-recognizing regulator. Specifying the molecular target and the readout keeps these mechanisms distinct.

A transcription elongation complex is the working assembly of RNA polymerase, its DNA template and the growing RNA during transcript extension. The RNA $3^{\prime }$ end is positioned for addition of the next nucleotide; a short DNA-RNA hybrid helps organize the nucleic acids inside the enzyme. Additional proteins can associate with this core assembly.

A 2001 RNA polymerase II crystal structure at $3.3\text{A˚}$ resolution showed entering duplex DNA, unwinding before the active site, and a nine-base pair DNA-RNA hybrid. Compared with free RNA polymerase II, the protein clamp closed around the nucleic acids. These observations connected a structurally identifiable assembly with ongoing transcription.^[ref]

For a sequence example, a template segment read $3^{\prime }$-TAC-$5^{\prime }$ specifies the complementary RNA segment $5^{\prime }$-AUG-$3^{\prime }$. Each addition extends the RNA while the complex advances relative to the template. This illustrates information flow; the three-letter example does not specify the complete set of contacts that stabilizes a real transcription elongation complex.

A transcription factor is a protein that regulates transcription. Combinations of transcription factors help select gene expression patterns during cell differentiation. ^[ref]

One of the distinct RNA products associated with a gene, differing through initiation, RNA splicing, end formation or other processing. Different transcript isoforms need not encode different proteins.

The trans-Golgi network is the sorting and export region at the trans side of the Golgi apparatus. Onward traffic can supply the cell membrane, secretory granules, or the lysosome route.^[ref]

Processing and sorting answer different questions. In a constructed example, two cargo proteins could receive the same carbohydrate modification yet carry different targeting information and leave in different transport vesicles. Conversely, two chemically different cargo proteins could share a destination. A processing readout alone therefore cannot establish the final address; an experiment must also identify cargo location or delivery. Return traffic and retention likewise matter: the Golgi apparatus is a working compartment, not merely a one-way queue that empties all of its enzymes into outgoing carriers.

For independent Poisson process arrivals of geometric translational bursts with mean $b$, arrival rate $\lambda$, and unit protein removal rate $\alpha N$, the stationary mean is $\bar{N}=\lambda b/\alpha$. Starting with zero molecules, the expected value is $m(t)=\bar{N}(1-e^{-\alpha t})$. The variance satisfies $v^{\prime }=\lambda b(1+2b)+\alpha m-2\alpha v$. An integrating factor gives the displayed expression, and its stationary limit is $\bar{N}(1+b)$. Concentration fluctuations require a specified cell volume to convert concentrations into molecule counts.

The expected number of proteins produced by one messenger RNA before its removal. With biological translation rate $r$ and exponential removal rate ${\alpha }_R$, $b=r/{\alpha }_R$. Independent Poisson biological translation during an exponential lifetime yields a geometric burst count on nonnegative integers, with variance $b(1+b)$. In the short-message-lifetime limit with independent unit protein removal, the protein Fano factor tends to $1+b$.